Artificial intelligence in prostate cancer: navigating the new frontier of precision uro-oncology
{{output}}
Artificial Intelligence (AI) is revolutionizing prostate cancer (PCa) care, addressing the major clinical challenges of subjectivity and overtreatment. Our traditional tools - like PSA, DRE, mpMRI, and Gleason scoring - often lack the precision needed to disti... ...
